TUCSON, Ariz., June 15, 2017 -- Contrary to decades of medical teaching that the brain and nervous system, once injured, cannot heal, the nervous system has significant capacity for repair and regeneration, write Timothy Marshall, Ph.D., and Carol Henricks, M.D., in the summer issue of the Journal of American Physicians and Surgeons.
About 2 million Americans suffer a traumatic brain injury (TBI) every year, as from concussion. Thousands of veterans have disabling damage due to blast exposure from improvised explosive devices (IEDs). Medications currently used to treat consequences such as depression, sleep disturbance, and cognitive problems may help some symptoms, but they do not promote healing or inhibit cell death or neurodegeneration, the authors note.
A new treatment model called biochemical restoration is emerging. Minerals that are especially important in reducing neuro-inflammation and promoting repair are lithium, magnesium, and zinc. Authors review some of the biochemical mechanisms in which these minerals are involved, such as regulating the function of more than 100 proteins.
Neurological repair, even in long-standing injury, is also stimulated by hyperbaric oxygenation therapy (HBOT), that is, breathing oxygen in a chamber under pressure, usually about 1.5 times atmospheric pressure. Authors explain that HBOT stimulates production of neurotrophic growth factors and the proliferation and mobilization of neural stem cells. It also modifies the expression of many genes and inhibits programmed cell death.
Authors conclude that “while there is currently no standard-of-care therapy that has been recognized to treat brain injury, which is too often considered hopeless, this could change with biochemical restoration therapy and hyperbaric oxygenation therapy (HBOT).” Much further research is needed to establish the most effective regimens.
The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since 1943.
Contact: Timothy Marshall, Ph.D., [email protected], Carol Henricks, M.D., (520) 229-1238, [email protected], or Jane M. Orient, M.D., (520) 323-3110, [email protected]


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Anta Sports Expands Global Footprint With Strategic Puma Stake
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Washington Post Publisher Will Lewis Steps Down After Layoffs
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



